Physics

Global 6G Communications Research Report 2023: Terahertz and Optical Materials, Components 2024-2044 with Technology Roadmaps

Retrieved on: 
Monday, March 11, 2024
VL, Physics, 2D, Visibility, Nine Lives, Chapter Ten, Infrared, FSO, Communication, Executive, Component, Conclusion, SWOT, Graphene, Infogram, Terahertz, Samsung, Huawei, Atmosphere, NTT, Fused quartz

DUBLIN, March 11, 2024 /PRNewswire/ -- The "6G Communications: Terahertz and Optical Materials, Components 2024-2044 with 32 Forecast Lines, Technology Roadmaps" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 11, 2024 /PRNewswire/ -- The "6G Communications: Terahertz and Optical Materials, Components 2024-2044 with 32 Forecast Lines, Technology Roadmaps" report has been added to ResearchAndMarkets.com's offering.
  • This unique report identifies your huge optical material and component opportunities from 6G Communications as it becomes primarily an optical system.
  • Its 58 pages contain the necessary explanations, new infograms, opportunity identification, leading players, SOFT appraisals, roadmaps and 17 forecasts all 2023-2043.
  • Here are the vital photovoltaic and other optical material manufacturing technologies involved with more on both later in the report.

Nusano Opens Radiochemistry Laboratory to Advance Isotope Commercialization and Customer Collaboration

Retrieved on: 
Monday, March 11, 2024
Actinium-225, Biotechnology, Drug development, Growth, Foot, Radionuclide, Risk, Radiochemistry, Physics, Health, Patient, Cancer

“Nusano is less than 12 months away from bringing critical, new radioisotope supplies to researchers, drugmakers and patients.

Key Points: 
  • “Nusano is less than 12 months away from bringing critical, new radioisotope supplies to researchers, drugmakers and patients.
  • We expect to begin producing non-carrier added lutetium-177 in Q1 2025, followed by actinium-225 in the second half of the year,” said Chris Lowe, CEO of Nusano.
  • Nusano is working to supply the fight against cancer by combining the company’s expertise in physics and radiochemistry to meet the medical isotope needs of today and enable the cancer radiotherapeutics of tomorrow.
  • Anna Goldberg, director of Radiochemistry and Production Operations for Nusano, added, “Nusano’s radiochemistry team is a world-class group of experts working at the forefront of their field.

Trinity University Receives Largest Gift in the University’s History for Naming of the D. R. Semmes School of Science

Retrieved on: 
Friday, March 8, 2024
Physics, Trinity University, Computer science, Research, Education, DoorDash, STEM, Mentorship, Molecular biology, Learning, Astronomy, Texas Biomedical Research Institute, Biochemistry, Faculty, University, School, History, Human, Council, Support, Southwest Research Institute, Microsoft, Advancement, Software, Student, Management

San Antonio, March 08, 2024 (GLOBE NEWSWIRE) -- With the largest gift in Trinity University’s history at $26.5 million, the University is honored to announce the naming of the D. R. Semmes School of Science .

Key Points: 
  • San Antonio, March 08, 2024 (GLOBE NEWSWIRE) -- With the largest gift in Trinity University’s history at $26.5 million, the University is honored to announce the naming of the D. R. Semmes School of Science .
  • “This investment by the Semmes Foundation accelerates our goal to deliver the best undergraduate science education in the United States,” said Vanessa B. Beasley, Ph.D., President of Trinity University.
  • “The sciences are at the core of a broad liberal arts education, and Trinity fundamentally understands this.
  • “We look forward to collaborating with Trinity and offering its students real-world experience in the sciences.”
    The history between the Semmes Foundation and Trinity University runs deep.

Unusual Machines Appoints FPV Drone Expert Andrew Camden as Chief Operating Officer

Retrieved on: 
Thursday, March 7, 2024
Acquisition, Physics, SAN, General Motors, FPV, Automotive industry, Engineering physics, Growth, Engineering, Tulane University, UMAC, Management

SAN JUAN, Puerto Rico, March 07, 2024 (GLOBE NEWSWIRE) -- Unusual Machines, Inc. (NYSE American: UMAC) (“Unusual Machines” or the “Company”), a drone and drone components manufacturer, announced today the appointment of First-Person View (“FPV”) drone expert Drew Camden as its Chief Operating Officer.

Key Points: 
  • SAN JUAN, Puerto Rico, March 07, 2024 (GLOBE NEWSWIRE) -- Unusual Machines, Inc. (NYSE American: UMAC) (“Unusual Machines” or the “Company”), a drone and drone components manufacturer, announced today the appointment of First-Person View (“FPV”) drone expert Drew Camden as its Chief Operating Officer.
  • Camden's ascent in the drone industry began with his captivating FPV Freestyle videos on YouTube.
  • Appointed President of Rotor Riot in 2018, Camden diversified the Rotor Riot by expanding media production and adding e-commerce.
  • Camden expressed his enthusiasm about the new role, stating, "I am excited to join Unusual Machines as Chief Operating Officer.

Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform

Retrieved on: 
Monday, March 4, 2024
Acquisition, Pharmacy, TMS, TRIUMF, Actinium-225, Chemistry, Isotope, Sale, TLX, Physics, ASX, Clinical trial, Science, Ultra, Research, Partnership, Medical imaging

MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. (ARTMS), its advanced cyclotron-based isotope production platform, manufacturing plant and stockpile of ultra-pure rare metals required for consumable target production.

Key Points: 
  • MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. (ARTMS), its advanced cyclotron-based isotope production platform, manufacturing plant and stockpile of ultra-pure rare metals required for consumable target production.
  • Telix is currently validating multiple production locations of large-scale 89Zr production in the United States (U.S.) using the QIS system and select manufacturing and pharmacy partners.
  • ARTMS and Telix have been collaborating since 20202 to evaluate the potential of higher curie-scale (Ci) production of Illuccix®.
  • As part of the acquisition, Telix will also acquire the benefit of ARTMS’s production facility and clean rooms, located in Burnaby, BC (Canada).

Lantronix Names Kurt Hoff as Vice President, Worldwide Sales

Retrieved on: 
Thursday, February 29, 2024
Conexant, Silicon Labs, University, Internet of things, Silicon, Sale, Physics, Knowledge, Champaign–Urbana metropolitan area, Laboratory, Management

IRVINE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions, today announced the appointment of Kurt Hoff as its vice president, Worldwide Sales, effective March 4, 2024.

Key Points: 
  • IRVINE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions, today announced the appointment of Kurt Hoff as its vice president, Worldwide Sales, effective March 4, 2024.
  • Hoff will replace Roger Holliday, vice president of Worldwide Sales at Lantronix, who is stepping down on Feb. 29, 2024, in order to retire.
  • “We are very pleased to welcome Kurt Hoff to the Lantronix leadership team,” said Saleel Awsare, president and CEO of Lantronix.
  • “Kurt’s knowledge and experience in the IoT industry, coupled with his abilities in scaling IoT revenue and profitability at industry leaders such as Silicon Labs, Synaptics and Conexant, makes him an excellent addition to the Lantronix team.”
    Prior to his appointment to Lantronix, Hoff served as senior vice president of Worldwide Sales at Synaptics Inc. (2017–2020) and senior vice president of Worldwide Sales at Silicon Laboratories Inc. (2007–2015).

AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors

Retrieved on: 
Wednesday, February 28, 2024
Research, Doctor of Philosophy, General partnership, Drug development, Growth, Frustration, University, Chronic pain, SUNY, Biomedical sciences, Epilepsy, Neurology, Rett syndrome, Smith, Kline & French, Acadia Pharmaceuticals, School, University at Buffalo, Biotechnology, ATyr Pharma, Health, Neurotoxicity, Cell, Therapy, DSM-IV codes, Brain, Neuropharmacology, Proteostasis, Amathus, Record, Drug discovery, Peripheral neuropathy, MPS, Physics, OPKO Health, Genomics, Acquisition, EMD, LoDo, Denver, MD, Organoid, Multiple sclerosis, Prevalence, Brown University, Brandeis University, Serono, Patient, Disease, GSK plc, Pharmaceutical industry

Dr. Pfost noted, “AxoSim embodies the entrepreneur’s sweet spot--when market need, technological innovation, timing and team all align. The growing prevalence of neurological diseases places enormous burdens on patients, their families and society. Yet despite billions in investment, neurology R&D continues to disappoint. AxoSim’s transformational approach addresses a key contributor to these failures—the lack of relevant disease models—by providing functional human data from its microphysiological system (MPS) organoid technologies early in the process. AxoSim aims to become an industry leader in helping to deliver urgently needed new drugs and I welcome the opportunity to contribute to its success.”

Key Points: 
  • Dr. Pfost and Dr. Weiner have decades of experience in building successful biotechnology companies spanning therapeutics, diagnostics and life science tools and technologies.
  • “Our recent acquisition of a third platform technology positions AxoSim for growth, and we are fortunate to have these two talented industry veterans assuming key leadership roles,” said Lowry Curley, PhD, co-founder and Chief Executive Officer of AxoSim.
  • “Dale and Dave bring successful track records in building life sciences businesses, with broad and complementary skill sets.
  • Dale’s work in life science tools and venture finance is highly relevant, as is Dave’s expertise in leading neurological drug discovery and clinical development.

Former EUROfusion CEO, Tony Donné, to Chair General Fusion’s Science and Technology Advisory Committee

Retrieved on: 
Wednesday, February 28, 2024
STAC, Neutron, Engineering, General Fusion, Magnetized target fusion, ITER, M.A, Stanford University, EUROfusion, Physics, UKAEA, LCLS, Organization, Plasma, Facility, Science, Research, European Patent Convention, SLAC National Accelerator Laboratory

RICHMOND, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Today, General Fusion announced the appointment of Tony Donné as Chair of its Science and Technology Advisory Committee (STAC).

Key Points: 
  • RICHMOND, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Today, General Fusion announced the appointment of Tony Donné as Chair of its Science and Technology Advisory Committee (STAC).
  • Prior to EUROfusion, Tony was head of the Fusion Physics Division at DIFFER and Director of the ITER-Netherlands program.
  • “General Fusion’s deeply engaged Science and Technology Advisory Committee is one of our biggest assets,” said Greg Twinney, CEO, General Fusion.
  • General Fusion Science and Technology Advisory Committee members:
    Tony Donné, Ph.D., Chair of General Fusion’s STAC and the former CEO of EUROfusion.

Comstock Announces Full Year 2023 Results

Retrieved on: 
Wednesday, February 28, 2024
Engineering, NSR, Economic development, Commercialization, TRL, HBO, Mining, AI, Trade, Investment, Research, Sale, Biomass, Hyperspectral imaging, Carbon, Alfredo De Gasperis, UPDATE, Physics, Biorefinery, Gold, Metal, HRSI, Silver, LEO, Renewable energy

VIRGINIA CITY, Nev., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced its full year 2023 results, 2023 summary achievements, and our 2024 business outlook.

Key Points: 
  • VIRGINIA CITY, Nev., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced its full year 2023 results, 2023 summary achievements, and our 2024 business outlook.
  • “I just toured our recycling facility, with all equipment in place and pre-commissioning activities well underway,” stated Mr. De Gasperis.
  • “Our 2023 achievements were foundational and established a shared corporate services platform that enables speed for each of our business teams,” stated Mr. De Gasperis.
  • On June 30, 2023, the Company signed a Mineral Exploration and Mining Lease Agreement (the “Mining Lease”) with Mackay Precious Metals Inc. (“Mackay").

What’s with the Extra Day? A College of Charleston Professor Explains Lear Year.

Retrieved on: 
Tuesday, February 27, 2024
Max Planck Society, Rotation, Calendar, Moon, College of Charleston, Astronomy, Season, Physics, Orbit, University, History, Science, Research, Travel

Our calendar year is based on the time it takes the Earth to complete one full orbit around the Sun.

Key Points: 
  • Our calendar year is based on the time it takes the Earth to complete one full orbit around the Sun.
  • So, in a non-leap year, after 365 days, the Earth would be slightly behind where it started relative to the Sun.
  • The Julian calendar added an extra day at the end of the year every four years.
  • Later on, two extra months were added to the calendar with February being made the last month of the year.